Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Braz. j. med. biol. res ; 29(8): 1019-24, Aug. 1996. ilus, tab
Article in English | LILACS | ID: lil-187372

ABSTRACT

We studied the effects of pancreas transplantation on kidney lesions of rats with alloxan-induced diabetes. Ninety inbred male Lewis rats were randomly assigned to 3 experimental groups: group NC included 30 non-diabetic control rats, group DC included 30 alloxan-induced diabetic control rats, and group PT include 30 alloxan-induced diabetic rats that received pancreas transplants from normal donor Lewis rats. Each group was further divided into 3 subgroups of 10 rats which were sacrificed at 1,3, and 6 months of follow-up, respectively. Clinical and laboratory parameters during these periods were documented. The kidneys of 5 rats in each subgroup were studied and 50 glomeruli and tubules from each kidney were analyzed by light microscopy by two different investigators in a double-blind study. There was progressive glomerular basement membrane thickening (GBMT), mesangial enlargement (ME), and Bowman's capsule thickening (BCT) in kidneys of rats in the 3 experimental groups during follow-up. These alterations were significantly higher in DC rats (GBMT: 1.99 ñ 0.31; ME: 2.00 ñ 0.33; BCT: 1.88 ñ 0.27) when compared to NC (GBMT: 1.54 ñ 0.30; ME: 1.56 ñ 0.47; BCT: 1.36 ñ 0.35) and PT rats (GBMT: 1.49 ñ 0.29; ME: 1.57 ñ 0.36; BCT: 1.35 ñ 0.28) at 6 months (P<0,01). The extent of GBMT, ME, and BCT observed in DC rats at 1 and 3 months was not significantly different from NC and PT rats. The amount of kidney lesions in PT rats was similar to that of NC rats and lower than those of DC rats at 6 months (P<0.01). In addition, Armanni-Ebstein lesions of the tubules (AE) and tubular lumen protein (PRO) observed in DC rats were not present in NC or PT rats. We conclude that pancreas transplantation in alloxan-induced diabetic rats prevents the development of kidney lesions beginning at 6 months after transplantation.


Subject(s)
Rats , Animals , Male , Diabetic Nephropathies/prevention & control , Pancreas Transplantation/pathology , Diabetes Mellitus, Experimental/therapy , Rats, Inbred Lew
2.
Braz. j. med. biol. res ; 28(9): 977-80, Sept. 1995. ilus
Article in English | LILACS | ID: lil-161088

ABSTRACT

Müller cells provide nutrition for neural cells. We studied the structure and ultrastructure of Müller cells in the retina of thirty 3-month old Wistar rats, divided equally into 3 groups: normal rats, alloxan diabetic rats and treated alloxan diabetic rats, 1 and 12 months after induction of diabetes. We observed that the Müller cell nuclei under light microscope examination had hexagonal shape and higher density than the other nuclei. Differences between groups could be observed only by electron microscopy. In the diabetic rats, Müller cells presented dispersion of nuclear chromatin and electrondense nuclear granulations, with the presence of increased glycogen, dense bodies and lysosomes in the cytoplasm. The alterations were more frequent in the perivascular region and at 12 months. The treated diabetic rats exhibited some alterations we observed in diabetic rats, but these alterations were less intense. We conclude that, despite the treatment, the diabetic retinopathy continues to evolve


Subject(s)
Animals , Rats , Diabetes Mellitus, Experimental/pathology , Neuroglia/ultrastructure , Diabetic Retinopathy/pathology , Alloxan , Insulin/administration & dosage , Rats, Wistar , Retina/ultrastructure
3.
Braz. j. med. biol. res ; 25(12): 1185-95, 1992. tab, graf
Article in English | LILACS | ID: lil-134497

ABSTRACT

1. Forty-five outbred Wistar rats were randomly assigned to three experimental groups: GI, 10 non-diabetic control rats; GII, 10 alloxan-diabetic control rats; GIII, 25 alloxan-diabetic rats which received pancreaticoduodenal transplantation (PDT) from normal Wistar donor rats and were immunosuppressed with cyclosporin A (Cy-A), 10 mg kg body weight-1 day-1, administered intraperitoneally for 30 days. 2. In parallel, 15 alloxan-diabetic inbred Wistar rats received isogeneic PDT from normal Wistar donor rats. 3. Cy-A prevented graft rejection in the 15 surviving animals in group III. These observations were confirmed by clinical and biochemical parameters (body weight, urine output, water and food intake, blood and urinary glucose and plasma insulin) and by histology and immunohistochemistry of the pancreas. 4. However, Cy-A was associated with 60% of the infectious complications in transplanted rats leading to 40% mortality. Pulmonary infections were the main cause of death. There were no side effects of immunosuppression on the pancreas. Infections were not significant in inbred rats submitted to PDT


Subject(s)
Animals , Male , Female , Cyclosporine/therapeutic use , Diabetes Mellitus, Experimental/surgery , Duodenum/transplantation , Immunosuppression Therapy/methods , Islets of Langerhans Transplantation/immunology , Drug Evaluation , Diabetes Mellitus, Experimental/immunology , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/pathology , Duodenum/immunology , Duodenum/pathology , Immunohistochemistry , Islets of Langerhans Transplantation/pathology , Pancreas/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL